Clinical characteristics of critically ill cancer patients who are undergoing isolated limb perfusion

Ñamendys-Silva,Silvio  A.; Ruiz-Beltran,Arturo  M.; Barragán‑Dessavre,Mireya; Bautista-Ocampo,Andoreni  R.; Meneses-García,Abelardo; González-Chon,Octavio; Herrera-Gómez,Angel

doi:10.3892/mco.2017.1401

November-2017 Volume 7 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2017 Volume 7 Issue 5

Full Size Image

Article Open Access

Clinical characteristics of critically ill cancer patients who are undergoing isolated limb perfusion

Authors:
- Silvio A. Ñamendys-Silva
- Arturo M. Ruiz-Beltran
- Mireya Barragán‑Dessavre
- Andoreni R. Bautista-Ocampo
- Abelardo Meneses-García
- Octavio González-Chon
- Angel Herrera-Gómez
View Affiliations / Copyright

Affiliations: Department of Critical Care Medicine, Instituto Nacional de Cancerología, Mexico City 14080, Mexico, Department of Critical Care Medicine, Fundación Clínica Médica Sur, Mexico City 14050, Mexico

Copyright: © Ñamendys-Silva et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 747-750
|
Published online on: August 31, 2017

https://doi.org/10.3892/mco.2017.1401
Expand metrics +

Abstract

The aim of the present study was to investigate the incidence of organ dysfunction, and to describe the clinical characteristics and intensive care unit (ICU) outcomes of critically ill cancer patients who were admitted to an oncological ICU during the isolated limb perfusion post-operative period. The present study was an observational investigation of 42 critically ill cancer patients who were admitted to the ICU of the Instituto Nacional de Cancerología, during the isolated limb perfusion post-operative period, between July 2010 and February 2016. The mean age of the patients was 45.7±16.9 years, and 45.2% (19 cases) were female. Soft tissue sarcoma was the most common pre-operative diagnosis (38.1%), and the mean duration of surgery was 267.6±50.1 min. Furthermore, a mean blood loss volume of 732.3±526.1 ml during the procedure was recorded, and the patients received a mean volume of 3.88±1.28 l crystalloid fluid during the surgical procedure, subsequently requiring an additional 2.95±6.28 l on the first post-operative day. The incidence of organ dysfunction was 90.5% and was most frequently noted in the respiratory (81%), hepatic (33%), hematologic (31%) and renal (11.9%) systems. No patients succumbed to the disease during the ICU and hospital stay. Nevertheless, <10% of the patients required vasopressors. Additionally, <5% of the patients required invasive mechanical ventilation. Therefore, ICU admission directly following isolated limb perfusion should not be standardized.

View Figures

View References

1	Smith HG, Cartwright J, Wilkinson MJ, Strauss DC, Thomas JM and Hayes AJ: Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma. Ann Surg Oncol. 22 Suppl 3:S356–S361. 2015. View Article : Google Scholar : PubMed/NCBI
2	Nieweg OE and Kroon BB: Isolated limb perfusion with melphalan for melanoma. J Surg Oncol. 109:332–337. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ruschulte H, Shi S, Tseng WW, Kolodzie K, Crawford PC, Schneider DB, Kashani-Sabet M, Minor D, Apfel C and Leong SP: Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: An analysis of 17 cases. BMC Anesthesiol. 13:152013. View Article : Google Scholar : PubMed/NCBI
4	Bhangu A, Broom L, Nepogodiev D, Gourevitch D and Desai A: Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: A systematic review. Eur J Surg Oncol. 39:311–319. 2013. View Article : Google Scholar : PubMed/NCBI
5	Vrouenraets BC, Kroon BB, Ogilvie AC, van Geel AN, Nieweg OE, Swaak AJ and Eggermont AM: Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-α and melphalan. Ann Surg Oncol. 6:405–412. 1999. View Article : Google Scholar : PubMed/NCBI
6	Saíd HM, Gómez AH, Ponce JLA and Jaime G: Perfusión Aislada de Extremidad. Una Alternativa a la Amputación en Tumores Avanzados por Melanoma, Sarcomas y Otros Tumores Irresecables de las Extremidades. Med Sr. 9:148–155. 2002.
7	Eggimann P, Chioléro R, Chassot PG, Lienard D, Gerain J and Lejeune F: Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest. 107:1074–1082. 1995. View Article : Google Scholar : PubMed/NCBI
8	Paulsen IF, Chakera AH, Schmidt G, Drejøe J, Klyver H, Oturai PS, Hesse B, Drzewiecki K and Mortensen J: Radionuclide leakage monitoring during hyperthermic isolated limb perfusion for treatment of local melanoma metastasis in an extremity. Clin Physiol Funct Imaging. 35:301–305. 2015. View Article : Google Scholar : PubMed/NCBI
9	Ñamendys-Silva SA, Silva-Medina MA, Vásquez-Barahona GM, Baltazar-Torres JA, Rivero-Sigarroa E, Fonseca-Lazcano JA and Domínguez-Cherit G: Application of a modified sequential organ failure assessment score to critically ill patients. Braz J Med Biol Res. 46:186–193. 2013. View Article : Google Scholar : PubMed/NCBI
10	Knaus WA, Draper EA, Wagner DP, Zimmerman JE and Apache II: APACHE II: A severity of disease classification system. Crit Care Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI
11	Bone RC, Balk RA, Cerra FB, et al: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20:864–874. 1992. View Article : Google Scholar : PubMed/NCBI
12	Lienard D, Ewalenko P, Delmotte JJ, Renard N and Lejeune FJ: High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 10:52–60. 1992. View Article : Google Scholar : PubMed/NCBI
13	Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N and Cascinelli N: Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer. 73:483–492. 1994. View Article : Google Scholar : PubMed/NCBI
14	Laurenzi L, Natoli S, Di Filippo F, Calamaro A, Centulio F, Anzà M, Cavaliere F, Marcelli ME, Garinei R and Arcuri E: Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-α. J Exp Clin Cancer Res. 23:225–231. 2004.PubMed/NCBI
15	Christoforidis D, Chassot PG, Mosimann F, Lienard D, Brunstein F, Bejko D, Lejeune FJ and Chiolero R: Isolated limb perfusion: Distinct tourniquet and tumor necrosis factor effects on the early hemodynamic response. Arch Surg. 138:17–25. 2003. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Clinical characteristics of critically ill cancer patients who are undergoing isolated limb perfusion

This article is mentioned in:

Abstract

Related Articles